Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study. Ruggieri S, Prosperini L, Al-Araji S, Annovazzi PO, et al. J Neurol Neurosurg Psychiatry 2023 Sep 29:jnnp-2023-331920.

Read + Share

Amedeo Smart

Independent Medical Education

Ruggieri S, Prosperini L, Al-Araji S, Annovazzi PO, et al. Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study. J Neurol Neurosurg Psychiatry 2023 Sep 29:jnnp-2023-331920.
PMID: 37775266